Replies to post #52605 on PharmaCyte Biotech Inc (PMCB)

[BioNewton]

That's right Wendy. The only question that no one answers is, "So what if trials don't start until 2017?" The real answer is....Who cares or It doesn't really matter.

As long as it starts. It's not a failure to have delays in Bio or during clinical trials. The failure is only if PMCB quits. Obviously Von Hoff won't let them do that.

[A_realist]

If only statements could translate into shareholder value then that would be great. In the real world only results matter.